# Psilocybin-Assisted Therapy in Treatment-Resistant Depression

> **NCT06303739** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 20 (actual)

## Conditions studied

- Refractory Depression
- Treatment Resistant Depression

## Interventions

- **DRUG:** psilocybin

## Key facts

- **NCT ID:** NCT06303739
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-04-19
- **Primary completion:** 2026-04-09
- **Final completion:** 2027-03-26
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2026-05-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06303739

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06303739, "Psilocybin-Assisted Therapy in Treatment-Resistant Depression". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT06303739. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*